Biological products, (no diagnostic substances) company · DE · FY ends Dec · -$80M FCF
Revenue declined 100.0% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$79M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
▼ -100.0% YoY
Net Income (TTM)
-$87M
▼ -28.3% YoY
Op. Margin
—
ROIC
-55.71%
▲ +4.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$80M
▼ -42.5% YoY
Op. Cash Flow (TTM)
-$78M
▼ -39.5% YoY
Net Debt
-$77M
Net Cash Position
Cash & Equiv.
$87M
Continue Research